Clinical Trials on CAR T-Cell Therapy in Australia
Total 90 results
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
OnxeoCompletedCutaneous T-cell LymphomaAustria, France, Germany, Switzerland
-
Dren BioNovotechRecruitingAggressive NK Cell Leukemia | Hepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Subcutaneous Panniculitis-Like T-Cell Lymphoma | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | LGLL - Large Granular Lymphocytic Leukemia | Primary Cutaneous T-Cell Lymphoma - Category and other conditionsUnited States, Australia, France, Spain
-
National Cancer Institute (NCI)CompletedCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States, Australia
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
Millennium Pharmaceuticals, Inc.Seagen Inc.CompletedMycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
-
Medical University of ViennaRecruiting
-
BioCryst PharmaceuticalsCompletedCutaneous T-cell Lymphoma (CTCL),United States, Australia, Germany, Italy, Spain, France, Austria, Finland, Switzerland, United Kingdom
-
Wugen, Inc.Enrolling by invitationT-cell Acute Lymphoblastic Leukemia | T-cell Lymphoblastic LymphomaUnited States, Australia
-
Spectrum Pharmaceuticals, IncTerminatedPeripheral T-cell LymphomaBelgium, Spain, United States, Australia, France, Israel, Canada, United Kingdom, New Zealand, Italy, Ireland, Poland, Puerto Rico
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Corvus Pharmaceuticals, Inc.Active, not recruitingT-cell LymphomaUnited States, China, Australia, Korea, Republic of
-
Daiichi SankyoActive, not recruitingRelapsed/Refractory Peripheral T-Cell Lymphoma | Adult T Cell Leukemia/LymphomaUnited States, Spain, Japan, United Kingdom, Korea, Republic of, France, Italy, Australia, Canada, Germany, Netherlands, Taiwan
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Eisai Inc.Dr. Reddy's Laboratory; Citius PharmaceuticalsCompletedPersistent or Recurrent Cutaneous T-Cell LymphomaUnited States, Australia, Puerto Rico
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
Astex Pharmaceuticals, Inc.Active, not recruitingRelapsed/Refractory Peripheral T-cell LymphomaSpain, United States, Australia, France, United Kingdom, Italy, Poland
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompletedMultiple Myeloma | Cutaneous LymphomaAustralia
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
Affimed GmbHCompletedPeripheral T Cell Lymphoma | Transformed Mycosis FungoidesSpain, United States, Korea, Republic of, Italy, France, Australia, Germany, Poland, Turkey, Russian Federation
-
Medical University of GrazUnknownLymphoproliferative Disorders | Psoriasis | Eczema | Pruritus | Vitiligo | Cutaneous T Cell Lymphoma | Mastocytosis | Graft Vs Host Disease | Lichen Planus | Prurigo | Polymorphic Light EruptionAustria
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, Australia, United Kingdom, Austria, Russian Federation, United States, Poland, Switzerland
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUntreated Childhood Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Neurotoxicity Syndrome | Childhood B Acute Lymphoblastic Leukemia | Cognitive Side Effects of Cancer Therapy | Psychological Impact of Cancer | Long-Term Effects Secondary to Cancer Therapy in ChildrenUnited States, Canada, Australia, New Zealand
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin Lymphoma | T-Cell Lymphoma | Anaplastic Large-Cell LymphomaUnited States, Korea, Republic of, Spain, United Kingdom, Taiwan, Czechia, Hungary, France, Israel, Germany, Italy, Denmark, Australia, Poland, Romania, Canada
-
SignPath Pharma, Inc.CompletedPatients w/Advanced Cancer That Failed Std of Care TherapyAustria
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
Arbeitsgemeinschaft medikamentoese TumortherapieTerminatedALK+ Anaplastic Large Cell LymphomaAustria
-
Wugen, Inc.RecruitingLymphoblastic Lymphoma | T-cell Acute Lymphoblastic LeukemiaUnited States, Australia, Netherlands, France
-
Innate PharmaActive, not recruitingLymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeUnited States, Spain, France, Italy, Belgium, Austria, Germany, Poland
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.TerminatedLymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T CellUnited States, Australia
-
National Cancer Institute (NCI)Active, not recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States, Canada, Australia, New Zealand, Switzerland
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
Medical University of GrazCompletedPatch/Plaque Stage Mycosis FungoidesAustria
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
Aarhus University HospitalGCP-unit at Aarhus University Hospital, Aarhus, DenmarkCompletedLymphoma, T-Cell, PeripheralNorway, Belgium, Finland, Denmark, Austria, Czechia, Portugal, Germany, Netherlands, Poland, Sweden